NASDAQ
18.09.26 | 21:59
1,970 US-Dollar
+0,51 % +0,010
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Full Transcript: Icecure Medical Q2 2026 Earnings Call | 3 | Benzinga.com | ||
| 11.09. | IceCure Secures China NMPA Approval for ProSense Cryoablation System | 1 | Zacks | ||
| 10.09. | IceCure Medical wins China approval for ProSense cryoablation system | 2 | Seeking Alpha | ||
| 10.09. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 24.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.08. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.08. | IceCure Medical GAAP EPS of -$3.17 misses by $1.65, revenue of $1.82M beats by $0.37M | 3 | Seeking Alpha | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.08. | IceCure Medical: IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year | 248 | PR Newswire | The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following... ► Artikel lesen | |
| 06.08. | IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment | 190 | PR Newswire | Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval
The site will... ► Artikel lesen | |
| 26.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 26.06. | What's Going On With IceCure Medical Stock On Friday? | 6 | Benzinga.com | ||
| 25.06. | IceCure Medical: IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement | 177 | PR Newswire | CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive... ► Artikel lesen | |
| 18.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.06. | IceCure Medical: IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance | 525 | PR Newswire | Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated... ► Artikel lesen | |
| 02.06. | IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance | 1 | Seeking Alpha | ||
| 02.06. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.06. | IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | 455 | PR Newswire | Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy
CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical... ► Artikel lesen | |
| 19.05. | IceCure Medical: IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked | 294 | PR Newswire | At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and... ► Artikel lesen | |
| 13.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.05. | IceCure Medical: IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement | 363 | PR Newswire | No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares
CAESAREA, Israel, May 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM)... ► Artikel lesen |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BILLIONTOONE | 105,92 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| FRESENIUS | 45,920 | -0,42 % | Vonovia sackt ab, Fresenius zieht an: DAX-Ausblick | Der DAX hat sich der abgelaufenen Woche weiter von seinem Rekordhoch entfernt. Unter dem Strich büßte das größte deutsche Börsenbarometer fast 500 Punkte ein und schloss -1,87% tiefer mit 25.559 Punkten.... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,770 | -1,69 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,690 | -0,79 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,130 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| MIMEDX | 4,770 | 0,00 % | Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 | ||
| BRIGHTSPRING HEALTH SERVICES | 56,76 | 0,00 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| BETA BIONICS | 21,890 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock | IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its... ► Artikel lesen | |
| HEARTFLOW | 50,65 | -0,20 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,335 | -0,18 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| ANTERIS TECHNOLOGIES GLOBAL | 8,160 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Compensatory Arrangements of Certain Officers | ||
| LIFESTANCE HEALTH GROUP | 12,575 | +0,04 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| AVEANNA HEALTHCARE | 13,655 | -0,11 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| CARL ZEISS MEDITEC | 29,460 | +1,52 % | SFC Energy, Dürr, Carl Zeiss Meditec, SFC Energy schauen nach Dehli zum BRIC's Gipfel - und Trump golft | Zeitenwende. Die Musik spielt in Dehli. Carl Zeiss MediTec, SFC Energy, Dürr, Wacker Chemie - you name it. Deutsche Small- und MidCaps müssen die Chance der Veränderung nutzen. Vielelicht noch mehr... ► Artikel lesen | |
| GENEDX | 101,09 | -0,01 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,010 (+0,51 %) liegt der Kurs bei 1,970 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.